Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 11—November 2024
Research

Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021–2022

Dongwon Yoon1, Kyungyeon Jung1, Ju Hwan Kim, Hwa Yeon Ko, Byeol-A Yoon2, Ju-Young Shin2Comments to Author , and CoVaSC Investigators
Author affiliation: Sungkyunkwan University Department of Biohealth Regulatory Science, Suwon, South Korea (D. Yoon, K. Jung, J.H. Kim, J.-Y. Shin); Sungkyunkwan University School of Pharmacy, Suwon (D. Yoon, J.H. Kim, H.Y. Ko, J.-Y. Shin); Dong-A University College of Medicine Department of Neurology, Busan, South Korea (B.-A. Yoon); Sungkyunkwan University Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Seoul, South Korea (J.-Y. Shin)

Main Article

Figure 3

Forest plot of sensitivity analyses of risk for facial palsy after COVID-19 vaccination in South Korea, 2021–2022. Overall risk is shown, as is risk stratified by adverse events of interest. Squares indicate IRRs; bars indicate 95% CIs. 1st/2nd dose indicates a first dose of BNT162b2, mRNA-1273, ChAdOx1 nCoV-19, or Ad26.COV2.S and a second dose of BNT162b2, mRNA-1273, or ChAdOx1 nCoV-19. IR, incidence rate; IRR, incidence rate ratio; NA, not applicable.

Figure 3. Forest plot of sensitivity analyses of risk for facial palsy after COVID-19 vaccination in South Korea, 2021–2022. Overall risk is shown, as is risk stratified by adverse events of interest. Squares indicate IRRs; bars indicate 95% CIs. 1st/2nd dose indicates a first dose of BNT162b2, mRNA-1273, ChAdOx1 nCoV-19, or Ad26.COV2.S and a second dose of BNT162b2, mRNA-1273, or ChAdOx1 nCoV-19. IR, incidence rate; IRR, incidence rate ratio; NA, not applicable.

Main Article

1These first authors contributed equally to this article.

2These last authors contributed equally to this article.

Page created: August 28, 2024
Page updated: October 22, 2024
Page reviewed: October 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external